Posts tagged USF Research
The ACTIV-4 Trial aims to reduce venous thromboembolism (blood clot) risk in patients with covid-19 with apixaban or aspirin.

Dr. Jason Wilson discusses the ACTIV-4 trial. This trial is a part of Operation Warp Speed, a federal government funded effort to rapidly develop vaccines and therapeutic modalities to treat, prevent, or minimize side effects of Covid through the Accelerating Covid-19 Therapeutic Interventions and Vaccines (ACTIV) protocols. ACTIV-4 investigates the use of Abixiban and Aspirin in preventing VTE in Covid-19 patients.

Read More